DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Small EJ. et al
Final survival results from SPARTAN, a phase III study of apalutamide versus placebo in patients with nonmetastatic castration-resistant prostate cancer..
ASCO 2020 Abstract 5516
Access:
We do not assume any responsibility for the contents of the web pages of other providers.